Are You Prioritizing Participant Safety in Your Vaccine Trials? 

Are You Prioritizing Participant Safety in Your Vaccine Trials Webinar Xtalks
Participant safety is the top priority in vaccine clinical trials. Effective safety tracking ensures not only regulatory compliance but also better trial outcomes, improved patient retention, and high-quality data. But how can research teams achieve this without increasing the operational burden?

Join Our Exclusive Webinar – Tracking Participant Safety in Vaccine Clinical Trials here

Date: Friday, March 7, 2025

Time: 2 PM EST

This webinar brings together industry experts to discuss practical, real-world strategies for improving safety tracking in vaccine trials. Key topics include:

 

  • Proactive Safety Monitoring: Learn how prebuilt symptom libraries help detect and manage risks earlier.
  • Innovative eTools: Learn about the latest digital tools designed to simplify participant engagement and enhance compliance tracking, making trials more efficient and participant-friendly
  • Safety-Centric Case Studies: Examine real-life examples of how enhanced safety tracking measures have improved outcomes in vaccine trials, demonstrating the tangible benefits of focused safety protocols

Why Attend?

Attendees will gain valuable insights about:

  • How to improve efficiency with a system purpose-built for vaccine trials
  • eTools that simplify participant engagement and compliance tracking
  • Real-life examples of improved vaccine trials
  • How to use real-time visibility with dashboards showing safety and efficacy data for both sites and sponsors/CROs

Speakers

Svetlana Rayner

Svetlana Rayner, Head of Statistical Science and Data Management, HilleVax

Svetlana Rayner is a dedicated, reliable, and proactive biometrics professional with over 15 years of experience in health government organizations and the pharmaceutical industry—she is a fast learner with comprehensive and wide-ranging subject knowledge and a clear communication style. Experience as an individual contributor, project lead, and team lead, supporting clinical development, marketing, and commercialization across various therapeutic areas, including vaccines and rare diseases.

Jose Jimeno

Jose Jimeno, CEO, Vaxtrials

Jose Jimeno is passionate about serving others. He believes vaccines are a powerful tool to overcome inequity and to help and serve many people. Knowing that VaxTrials contributes to eradicating preventable diseases by decreasing the time to market different vaccines is a strong motivation for him.

He is a physician with more than 15 years of experience in vaccine clinical research, including contract research organization services and industry-sponsored clinical studies. Vaxtrials brings together industry experts in vaccine clinical trials and healthcare in the Latin American Region.

Make participant safety in vaccine trials a priority.
Join us for expert insights!

Share This Post

More To Explore

Are you planning your site's 2024 budget Trial 360

Are you planning your site’s 2024 budget?

Around this season, many research sites are planning and projecting their budget for the upcoming year 2024; this is an excellent opportunity to consider a

error: Content is protected !!